Despite a more than 20-year experience of therapeutic benefit, the relevant molecular and
cellular targets of intravenous immunoglobulin (IVIg) in autoimmune disease remain unclear. …

There is a growing trend to design hybrid neural networks (HNNs) by combining spiking
neural networks and artificial neural networks to leverage the strengths of both. Here, we …

Although the mechanism of action of intravenous immunoglobulin (IVIg) in treating antibody‐dependent
thrombocytopenia remains unclear, most studies have suggested that IVIg …

Intravenous immunoglobulin (IVIG) is currently used to treat a multitude of autoimmune disorders
including immune thrombocytopenic purpura (ITP), yet the mechanism of action of IVIG …

It has been established that amelioration of murine immune thrombocytopenia purpura (ITP)
by IVIg is dependent on the inhibitory receptor FcγRIIB. Co-cross-linking of the FcγRIIB with …

Background By genetic analysis, the CAG repeat expansion has been established in
spinocerebellar ataxia (SCA) types 1, 2, 3, 6, and 7. Despite the genetic differentiation of SCA, the …

Intravenous Ig (IVIg) mediates protection from the effects of immune thrombocytopenic purpura
(ITP) as well as numerous other autoimmune states; however, the active antibodies within …

Intravenous immunoglobulin (IVIG) is used to treat immune thrombocytopenia resulting from
a variety of autoimmune and nonautoimmune diseases such as idiopathic …

Interleukin-10 (IL-10) is a potent monocyte regulatory cytokine that inhibits gene expression
of proinflammatory mediators. In this study, we investigated the mechanism by which IL-10 …

Mucolipidosis types II and III are autosomal recessive inherited diseases caused by a
deficiency in the lysosomal enzyme N‐acetylglucosamine‐1 phosphotransferase (GlcNAc‐…